4,290
Views
10
CrossRef citations to date
0
Altmetric
Review Articles

Evidence and potential mechanisms of traditional Chinese medicine for the treatment of psoriasis vulgaris: a systematic review and meta-analysis

ORCID Icon, ORCID Icon, , , &
Pages 671-681 | Received 23 May 2020, Accepted 14 Jun 2020, Published online: 09 Jul 2020

References

  • Greb JE, Goldminz AM, Elder JT, et al. Psoriasis. Nat Rev Dis Primers. 2016;242:16082.
  • Boehncke WH, Schon MP. Psoriasis. Lancet. 2015;386(9997):983–994.
  • Rendon A, Schakel K. Psoriasis pathogenesis and treatment. Int J Mol Sci. 2019;20(6):1475.
  • Jensen P, Skov L. Psoriasis and obesity. Dermatology (Basel). 2016;232(6):633–639.
  • Liang SE, Cohen JM, Ho RS. Screening for depression and suicidality in psoriasis patients: a survey of US dermatologists. J Am Acad Dermatol. 2019;80(5):1460–1462.
  • Dauden E, Carretero G, Rivera R, et al. Long term safety of nine systemic medications for psoriasis: a cohort study using the Biobadaderm Registry. J Am Acad Dermatol. 2020;83(1):139–150.
  • Cui Y. Clinical curative effect of using Liangxue Tuyin decoction in the treatment of psoriasis with blood-heat syndrome and its effect on accelerating skin lesion. J Sichuan Tradit Chin Med. 2019;37(07):151–154.
  • Ding R. Observation on the therapeutic effect of Ziyin Huoxue Runzao decoction combined with Western Medicine in the treatment of plaque Psoriasis. Mod J Integr Tradit Chin Western Med. 2017;26(18):2030–2032 + 2043.
  • Huang QH, Lin JJ. Observation on the Therapeutic effect of combination of traditional Chinese and Western Medicine on psoriasis vulgaris. J Dermatol Venereol. 2019;41(06):820–822.
  • Li TT, Wang P, Zhou DM, et al. Clinical observation of Huoxue Jiedu decoction for psoriasis vulgaris of Blood stasis syndrome. J Pract Dermatol. 2016;9(02):133–135 + 138.
  • Long HQ, Chen L, Bi DD, et al. Observation on the efficacy and safety of integrated traditional Chinese and Western Medicine in the treatment of psoriasis vulgaris. J Dermatol Venereol. 2018;40(06):839–840.
  • She YY. A Clinical Research on The Treatment of psoriasis vulgaris in stationary stage blood dryness syndrome, blood stasis syndrome with calm-the-mind-and-relieve-itching formula. China Academy of Chinese Medical Sciences; 2017.
  • Wang WN. Observation of the curative effect of the silver soup combined with seedlings medicine away tinea pill treatment of psoriasis with wind-hot-and-blood-dryness syndrome. Guiyang University of Chinese Medicine; 2012.
  • Wu J. Clinical study on the treatment of retrograde psoriasis vulgaris by Peiyuan Yifu Purging. Yunnan University of Chinese Medicine; 2019.
  • Wu Y-M, Li Q. Jianpi Jiedu Tang combined with avermectin A for training plaque psoriasis: a report of 80 cases. Liaoning J Tradit Chin Med. 2015;42(3):547–548.
  • Yang F, Wang H, Qin T. Observation on the therapeutic effect of Qingre Liangxue Xiaoyin decoction combined with acitretin capsule in the treatment of psoriasis vulgaris. Shaanxi J Tradit Chin Med. 2017;38(11):1568–1569.
  • Yao SP, Zhang CH, Guo F, et al. Clinical study on plaque psoriasis treated by spleen-strengthening and detoxification decoction combined with Avi A. China J Tradit Chin Med Pharmacy. 2013;28(09):2798–2800.
  • Yuan LL. Effect of Qingre Huoxue Jiedu Prescription on Psoriasis NGF and CREB Signal Transduction Network. China Academy of Chinese Medical Sciences; 2019.
  • Zhang CH. Efficacy of Tripterygium hypoglaucum (levl.) hutch mixture in blood-heat type of psoriasis vulgaris and its effect on IL-12 and IL-23. Yunnan University of Chinese Medicine; 2017.
  • Zhang L. The clinical observation and immune adjustment of oxymatrine capsule and actretin in the treatment of psoriasis. J Chin Phys. 2013;15(3):331–333.
  • Zhou DM. Wang Jusheng's academic thoughts and clinical experiences and the clinical study of treating psoriasis through blood differentiation. Beijing University of Chinese Medicine; 2011.
  • Zhou MJ. Study of the Mechanisms of Liangxuehuoxue complex prescription on progressive psoriasis. Dalian Medical University; 2012.
  • Zhu XY. Clinical observation in the treatment of psoriasis vulgaris by Yu Shi Xiao Bi Yin decoction. Zhejiang Chinese Medical University; 2014.
  • Zhou Y, Guo X, Chen W, et al. Angelica polysaccharide mitigates lipopolysaccharide-evoked inflammatory injury by regulating microRNA-10a in neuronal cell line HT22. Artif Cells Nanomed Biotechnol. 2019;47(1):3194–3201.
  • Wang W, Yuhai  , Wang H, et al. Astilbin reduces ROS accumulation and VEGF expression through Nrf2 in psoriasis-like skin disease. Biol Res. 2019;52(1):49.
  • Zhang C, Xu Q, Tan X, et al. Astilbin decreases proliferation and improves differentiation in HaCaT keratinocytes. Biomed Pharmacother. 2017;93:713–720.
  • Parker S, Zhang CS, Yu JJ, et al. Oral Chinese herbal medicine versus placebo for psoriasis vulgaris: a systematic review. J Dermatolog Treat. 2017;28(1):21–31.
  • Zhang CS, Yang L, Zhang AL, et al. Is oral Chinese herbal medicine beneficial for psoriasis vulgaris? A meta-analysis of comparisons with acitretin. J Altern Complement Med. 2016;22(3):174–188.
  • Zhang CS, Yu JJ, Parker S, et al. Oral Chinese herbal medicine combined with pharmacotherapy for psoriasis vulgaris: a systematic review. Int J Dermatol. 2014;53(11):1305–1318.
  • Jadad AR, Moore RA, Carroll D, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 1996;17(1):1–12.
  • Yang L, Feng X, Li Y, et al. Therapeutic efficacy of catalpol against apoptosis in cardiomyocytes derived from human induced pluripotent stem cells. AMB Express. 2020;10(1):56.
  • Xu DQ, Li CJ, Jiang ZZ, et al. The hypoglycemic mechanism of catalpol involves increased AMPK-mediated mitochondrial biogenesis. Acta Pharmacol Sin. 2020;41(6):791–799.
  • Wang ZH, Zhan-Sheng H. Catalpol inhibits migration and induces apoptosis in gastric cancer cells and in athymic nude mice. Biomed Pharmacother. 2018;103:1708–1719.
  • Li FL, Xu R, Zeng QC, et al. Tanshinone IIA inhibits growth of keratinocytes through cell cycle arrest and apoptosis: underlying treatment mechanism of psoriasis. Evid Based Complement Alternat Med. 2012;2012:927658.
  • Lu J, Zhou H, Meng D, et al. Tanshinone IIA improves depression-like behavior in mice by activating the ERK-CREB-BDNF signaling pathway. Neuroscience. 2020;430:1–11.
  • Yang G, Wang F, Wang Y, et al. Protective effect of tanshinone IIA on H2O2-induced oxidative stress injury in rat cardiomyocytes by activating Nrf2 pathway. J Recept Signal Transduct Res. 2020;40(3):1–9.
  • Ren F, Li J, Wang Y, et al. The effects of angelica sinensis polysaccharide on tumor growth and iron metabolism by regulating hepcidin in tumor-bearing mice. Cell Physiol Biochem. 2018;47(3):1084–1094.
  • Di TT, Ruan ZT, Zhao JX, et al. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway. Int Immunopharmacol. 2016;32:32–38.
  • Yu YJ, Xu YY, Lan XO, et al Shikonin induces apoptosis and suppresses growth in keratinocytes via CEBP-δ upregulation. Int Immunopharmacol. 2019;72:511–521.
  • Ma C, Wei Y, Liu Q, et al. Polysaccharides from Hedyotis diffusa enhance the antitumor activities of cytokine-induced killer cells. Biomed Pharmacother. 2019;117:109167.
  • Lin L, Cheng K, Xie Z, et al. Purification and characterization a polysaccharide from Hedyotis diffusa and its apoptosis inducing activity toward human lung cancer cell line A549. Int. J. Biol. Macromol. 2019;122:64–71.
  • Xu Y, Xu X, Gao X, et al. Shikonin suppresses IL-17-induced VEGF expression via blockage of JAK2/STAT3 pathway. Int. Immunopharmacol. 2014;19(2):327–333.
  • Zhang X, Li J, Yu Y, et al Shikonin controls the differentiation of CD4 + CD25+ regulatory T cells by inhibiting AKT/mTOR pathway. Inflammation. 2019;42(4):1215–1227.
  • Meng Y, Wang M, Xie X, et al. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells. International Journal of Molecular Medicine. 2017;39(5):1101–1110.
  • Li B, He S, Liu R, et al. Total glucosides of paeony attenuates animal psoriasis induced inflammatory response through inhibiting STAT1 and STAT3 phosphorylation. J Ethnopharmacol. 2019;243:112121.
  • Xiong H, Xu Y, Tan G, et al Glycyrrhizin ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice and inhibits TNF-α-induced ICAM-1 expression via NF-κB/MAPK in HaCaT cells. Cell Physiol Biochem. 2015;35(4):1335–1346.
  • Oji V, Luger TA. The skin in psoriasis: assessment and challenges. Clin Exp Rheumatol. 2015;33(5 Suppl 93):S14–S19.
  • Medicine. DBoCAoC, Medicine. DscoBAoC. Dermatology and venereology speciality committee BaotioTaWm. Evidence-based clinical practice guide of traditional Chinese medicine for psoriasis vulgaris. J Tradit Chin Med. 2014;55(01):76–82.
  • Alqarni AM, Zeidler MP. How does methotrexate work? Biochem Soc Trans. 2020;48(2):559–567.
  • Cronstein BN, Aune TM. Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol. 2020;16(3):145–154.
  • Qin X, Chen C, Zhang Y, et al. Acitretin modulates HaCaT cells proliferation through STAT1- and STAT3-dependent signaling. Saudi Pharm J. 2017;25(4):620–624.
  • Niu X, Cao W, Ma H, et al. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris. J Dermatol. 2012;39(11):916–921.
  • Menter A, Strober BE, Kaplan DH, et al. Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with biologics. J Am Acad Dermatol. 2019;80(4):1029–1072.
  • Borren NZ, Ananthakrishnan AN. Safety of biologic therapy in older patients with immune-mediated diseases: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2019;17(9):1736–1743.e4.
  • Hu JZ, Billings SD, Yan D, et al. Histologic comparison of tumor necrosis factor-alpha inhibitor-induced psoriasis and psoriasis vulgaris. J Am Acad Dermatol. 2020;83(1):71–77.